Molecular Dynamics-Based Virtual Screening: Accelerating the Drug Discovery Process by High-Performance Computing

2013 ◽  
Vol 53 (10) ◽  
pp. 2757-2764 ◽  
Author(s):  
Hu Ge ◽  
Yu Wang ◽  
Chanjuan Li ◽  
Nanhao Chen ◽  
Yufang Xie ◽  
...  
2020 ◽  
Author(s):  
Pedro Ballester

Interest in docking technologies has grown parallel to the ever increasing number and diversity of 3D models for macromolecular therapeutic targets. Structure-Based Virtual Screening (SBVS) aims at leveraging these experimental structures to discover the necessary starting points for the drug discovery process. It is now established that Machine Learning (ML) can strongly enhance the predictive accuracy of scoring functions for SBVS by exploiting large datasets from targets, molecules and their associations. However, with greater choice, the question of which ML-based scoring function is the most suitable for prospective use on a given target has gained importance. Here we analyse two approaches to select an existing scoring function for the target along with a third approach consisting in generating a scoring function tailored to the target. These analyses required discussing the limitations of popular SBVS benchmarks, the alternatives to benchmark scoring functions for SBVS and how to generate them or use them using freely-available software.


2020 ◽  
Vol 15 (9) ◽  
pp. 981-985
Author(s):  
Savíns Puertas-Martín ◽  
Antonio J. Banegas-Luna ◽  
María Paredes-Ramos ◽  
Juana L. Redondo ◽  
Pilar M. Ortigosa ◽  
...  

2020 ◽  
Author(s):  
Pedro Ballester

Interest in docking technologies has grown parallel to the ever increasing number and diversity of 3D models for macromolecular therapeutic targets. Structure-Based Virtual Screening (SBVS) aims at leveraging these experimental structures to discover the necessary starting points for the drug discovery process. It is now established that Machine Learning (ML) can strongly enhance the predictive accuracy of scoring functions for SBVS by exploiting large datasets from targets, molecules and their associations. However, with greater choice, the question of which ML-based scoring function is the most suitable for prospective use on a given target has gained importance. Here we analyse two approaches to select an existing scoring function for the target along with a third approach consisting in generating a scoring function tailored to the target. These analyses required discussing the limitations of popular SBVS benchmarks, the alternatives to benchmark scoring functions for SBVS and how to generate them or use them using freely-available software.


2018 ◽  
Vol 11 (3) ◽  
pp. 1513-1519 ◽  
Author(s):  
R. Ani ◽  
Roshini Manohar ◽  
Gayathri Anil ◽  
O.S. Deepa

In earlier years, the Drug discovery process took years to identify and process a Drug. It takes a normal of 12 years for a Drug to travel from the research lab to the patient. With the introduction of Machine Learning in Drug discovery, the whole process turned out to be simple. The utilization of computational tools in the early stages of Drug development has expanded in recent decades. A computational procedure carried out in Drug discovery process is Virtual Screening (VS). VS are used to identify the compounds which can bind to a Drug target. The preliminary process before analyzing the bonding of ligand and drug protein target is the prediction of drug likeness of compounds. The main objective of this study is to predict Drug likeness properties of Drug compounds based on molecular descriptor information using Tree based ensembles. In this study, many classification algorithms are analyzed and the accuracy for the prediction of drug likeness is calculated. The study shows that accuracy of rotation forest outperforms the accuracy of other classification algorithms in the prediction of drug likeness of chemical compounds. The measured accuracies of the Rotation Forest, Random Forest, Support Vector Machines, KNN, Decision Tree and Naïve Bayes are 98%, 97%, 94.8%, 92.8%, 91.4%, 89.5% respectively.


2017 ◽  
Vol 29 (3) ◽  
Author(s):  
Mabule Samuel Mabakane ◽  
Daniel Mojalefa Moeketsi ◽  
Anton Lopis

This paper presents a case study on the scalability of several versions of the molecular dynamics code (DL_POLY) performed on South Africa‘s Centre for High Performance Computing e1350 IBM Linux cluster, Sun system and Lengau supercomputers. Within this study different problem sizes were designed and the same chosen systems were employed in order to test the performance of DL_POLY using weak and strong scalability. It was found that the speed-up results for the small systems were better than large systems on both Ethernet and Infiniband network. However, simulations of large systems in DL_POLY performed well using Infiniband network on Lengau cluster as compared to e1350 and Sun supercomputer.


Author(s):  
Gurusamy Mariappan ◽  
Anju Kumari

Virtual screening plays an important role in the modern drug discovery process. The pharma companies invest huge amounts of money and time in drug discovery and screening. However, at the final stage of clinical trials, several molecules fail, which results in a large financial loss. To overcome this, a virtual screening tool was developed with super predictive power. The virtual screening tool is not only restricted tool small molecules but also to macromolecules such as protein, enzyme, receptors, etc. This gives an insight into structure-based and Ligand-based drug design. VS gives reliable information to direct the process of drug discovery (e.g., when the 3D image of the receptor is known, structure-based drug design is recommended). The pharmacophore-based model is advisable when the information about the receptor or any macromolecule is unknown. In this ADME, parameters such as Log P, bioavailability, and QSAR can be used as filters. This chapter shows both models with various representative examples that facilitate the scientist to use computational screening tools in modern drug discovery processes.


2016 ◽  
Vol 17 (14) ◽  
pp. 1578-1579
Author(s):  
Horacio Pérez-Sánchez ◽  
Sandra Gesing ◽  
Ivan Merelli

Author(s):  
Joachim Hein ◽  
Fiona Reid ◽  
Lorna Smith ◽  
Ian Bush ◽  
Martyn Guest ◽  
...  

The effective exploitation of current high performance computing (HPC) platforms in molecular simulation relies on the ability of the present generation of parallel molecular dynamics code to make effective utilisation of these platforms and their components, including CPUs and memory. In this paper, we investigate the efficiency and scaling of a series of popular molecular dynamics codes on the UK's national HPC resources, an IBM p690+ cluster and an SGI Altix 3700. Focusing primarily on the Amber , Dl_Poly and Namd simulation codes, we demonstrate the major performance and scalability advantages that arise through a distributed, rather than a replicated data approach.


Sign in / Sign up

Export Citation Format

Share Document